Inotuzumab Ozogamicin - PF-05208773

Multiple Oritavancin Doses on Safety, Tolerability, and Pharmacokinetics in Healthy Subjects

NCT02470702 ·Status: COMPLETED ·Phase: PHASE1

Individual Patient Expanded Access for AB-PA01, an Investigational Anti-Pseudomonas Aeruginosa Bacteriophage Therapeutic

NCT03395743 ·Status: NO_LONGER_AVAILABLE

A Study of Benzathine Benzylpenicillin Intramuscular Injection in Japanese Healthy Subjects

NCT03612557 ·Status: COMPLETED ·Phase: PHASE1

Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia

NCT04851015 ·Status: RECRUITING ·Phase: PHASE3

A Study to Learn About the Study Medicine Called CTB+AVP in Healthy Adult People.

NCT05554237 ·Status: COMPLETED ·Phase: PHASE1

An Effectiveness, Safety, and Microbiology Study of Doripenem in Patients With Nosocomial (Hospital-acquired) Pneumonia

NCT00502801 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)

NCT02452047 ·Status: COMPLETED ·Phase: PHASE3

An Open-label, Randomized, Single Period, Parallel-Cohort Study To Evaluate Serum and Pulmonary Pharmacokinetics Following Single and Multiple Dose Administration of Intravenous GSK2251052 in Healthy Adult Subjects

NCT01267968 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Plasma, Epithelial Lining, and Alveolar Macrophage Concentrations of Intravenous Carbavance™ (RPX2014/RPX7009) in Healthy Adult Subjects

NCT02073812 ·Status: COMPLETED ·Phase: PHASE1

Safety and Pharmacokinetics of KBPA-101 in Hospital Acquired Pneumonia Caused by O11 Pseudomonas Aeruginosa

NCT00851435 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection (MK-7625A-014)

NCT02728089 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of the Treatment of Kidney Infections With Short Course Levofloxacin

NCT00239161 ·Status: TERMINATED ·Phase: PHASE4

A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Orbactiv® (Oritavancin) for Infections Caused by Gram Positive Bacteria in a Real World Setting

NCT03159403 ·Status: COMPLETED

A Study to Investigate the Pharmacokinetics of RO7079901 and Meropenem in Participants With a Complicated Urinary Tract Infection

NCT03174795 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Cardiac Safety of Oritavancin in Healthy Participants

NCT01762839 ·Status: COMPLETED ·Phase: PHASE1

Intravenous Pentamidine for Pneumocystis Jirovecii Pneumonia

NCT02669706 ·Status: COMPLETED

Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections

NCT07089186 ·Status: RECRUITING ·Phase: PHASE3

Selective Digestive Decontamination in Carriers of Carbapenem-resistant Klebsiella Pneumoniae

NCT00753558 ·Status: COMPLETED ·Phase: NA

Adjunctive Therapeutic Treatment With Human Monoclonal Antibody AR-105 (Aerucin®) in P. Aeruginosa Pneumonia

NCT03027609 ·Status: COMPLETED ·Phase: PHASE2

GSK2251052 in Complicated Urinary Tract Infection

NCT01381549 ·Status: TERMINATED ·Phase: PHASE2

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7079901 and the Combination of RO7079901 With Meropenem in Adult Healthy Volunteers

NCT02972255 ·Status: COMPLETED ·Phase: PHASE1

Combo-PEP: Multipurpose Prevention of Post-Exposure Prophylaxis Regimens

NCT04860505 ·Status: COMPLETED ·Phase: PHASE4

A Study to Investigate the Intrapulmonary Lung Penetration of Nacubactam in Healthy Participants

NCT03182504 ·Status: COMPLETED ·Phase: PHASE1

A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses and Repeat Escalating Oral Doses of GSK2251052 in Healthy Adult Subjects

NCT01262885 ·Status: COMPLETED ·Phase: PHASE1

New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)

NCT00035269 ·Status: COMPLETED ·Phase: PHASE3